Colleen Reed is a dedicated Senior Clinical Trial Associate at Intra-Cellular Therapies, where she plays a pivotal role in advancing innovative treatments in the field of oncology. With a robust background in clinical monitoring and oncology clinical research, Colleen has become an integral part of...
Colleen Reed is a dedicated Senior Clinical Trial Associate at Intra-Cellular Therapies, where she plays a pivotal role in advancing innovative treatments in the field of oncology. With a robust background in clinical monitoring and oncology clinical research, Colleen has become an integral part of the clinical programs team, contributing her expertise to multiple clinical trials that aim to bring groundbreaking therapies to patients. Her strong self-directed work ethic and problem-solving orientation enable her to navigate the complexities of clinical trial management with ease.
In her current role, Colleen is responsible for organizing and managing critical study documents and materials, ensuring that all documentation adheres to Good Clinical Practice (GCP) standards. She meticulously manages the internal Trial Master File (TMF) and conducts thorough reviews of external TMFs, guaranteeing the quality and completeness of files essential for regulatory compliance. Her keen attention to detail and commitment to excellence are evident in her ability to streamline processes and enhance the efficiency of clinical trial operations.
Colleen’s exceptional communication skills shine through as she schedules and coordinates clinical project meetings, preparing comprehensive agendas and presentation materials that facilitate productive discussions among stakeholders. Her adaptability to change and rapid understanding of new principles and business technologies allow her to implement cost-effective and innovative solutions that drive project success. As a motivated team player, Colleen Reed continues to make significant contributions to Intra-Cellular Therapies, helping to shape the future of oncology research and improve patient outcomes.